Growth Metrics

GeneDx Holdings (WGSWW) Total Non-Current Liabilities (2020 - 2025)

GeneDx Holdings has reported Total Non-Current Liabilities over the past 6 years, most recently at $213.9 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $213.9 million for Q4 2025, up 26.85% from a year ago — trailing twelve months through Dec 2025 was $213.9 million (up 26.85% YoY), and the annual figure for FY2025 was $213.9 million, up 26.85%.
  • Total Non-Current Liabilities for Q4 2025 was $213.9 million at GeneDx Holdings, up from $197.4 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for WGSWW hit a ceiling of $407.6 million in Q2 2021 and a floor of $140.4 million in Q3 2023.
  • Median Total Non-Current Liabilities over the past 5 years was $184.1 million (2022), compared with a mean of $213.1 million.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 140.6% in 2021 and later plummeted 54.55% in 2022.
  • GeneDx Holdings' Total Non-Current Liabilities stood at $155.7 million in 2021, then skyrocketed by 36.9% to $213.2 million in 2022, then decreased by 17.45% to $176.0 million in 2023, then decreased by 4.2% to $168.6 million in 2024, then rose by 26.85% to $213.9 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $213.9 million (Q4 2025), $197.4 million (Q3 2025), and $183.5 million (Q2 2025) per Business Quant data.